ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,610Medicare Part D Prescriptions Filled, Including Refills

Rank: 131 out of 917

$402K Total Retail Price of All Prescriptions

Rank: 203 out of 917

426 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 426 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 426 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 7,887 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 459 418 1 1
SIMVASTATIN 336 326 2 2
AMLODIPINE BESYLATE 295 278 3 5
LEVOTHYROXINE SODIUM 293 245 4 3
OMEPRAZOLE 284 258 5 4
ATENOLOL 225 215 6 12
PRAVASTATIN SODIUM 190 171 7 20
HYDROCODONE-ACETAMINOPHEN 161 146 S3 8 6
HYDROCHLOROTHIAZIDE 156 136 9 9
FUROSEMIDE 154 154 10 7
POTASSIUM CHLORIDE 147 146 11 16
ZOLPIDEM TARTRATE 134 118 12 21
CITALOPRAM HBR 133 115 13 15
LOVASTATIN 129 113 14 19
METFORMIN HCL 126 113 15 8
LOSARTAN POTASSIUM 112 102 16 13
METOPROLOL SUCCINATE 110 106 17 18
PANTOPRAZOLE SODIUM 104 100 18 44
DIGOXIN 102 102 19 41
METOPROLOL TARTRATE 99 92 20 11
GABAPENTIN 96 88 21 17
SERTRALINE HCL 92 67 22 24
OXYCODONE HCL 90 66 S2 23 27
TAMSULOSIN HCL 88 75 24 25
GLIMEPIRIDE 86 86 25 54
WARFARIN SODIUM 86 86 25 10
ALENDRONATE SODIUM 86 86 25 23
ATORVASTATIN CALCIUM 81 81 28 14
ALLOPURINOL 81 77 28 31
BENAZEPRIL HCL 77 66 30 80
POLYETHYLENE GLYCOL 3350 73 69 31 66
PAROXETINE HCL 72 70 32 57
PREDNISONE 68 68 33 34
METFORMIN HCL ER 62 48 34 69
TRIAMTERENE-HCTZ 60 60 35 36
TRAZODONE HCL 60 55 35 22
BENICAR 59 59 37 104
RANITIDINE HCL 58 57 38 29
OLANZAPINE 57 47 39 103
DILTIAZEM 24HR CD 56 56 40 95
CEPHALEXIN 55 54 41 105
DIVALPROEX SODIUM 51 51 42 75
FLUTICASONE PROPIONATE 51 46 42 26
GLIPIZIDE XL 50 50 44 142
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 50 44 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 21, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.